Loading...

Larissa Maier, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
DepartmentPsychiatry
Address401 Parnassus Ave.
San Francisco CA 94143
Phone415-476-8575
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Zurich, ZurichB.Sc. 07/2010Psychology
    University of Zurich, ZurichM.Sc.07/2012Clinical Psychology
    King's College London, LondonFellowship09/2014Addiction Research
    University of Zurich, ZurichPh.D.03/2017Addiction Research
    UNODC, ViennaConsultancy12/2017Drug Use Epidemiology
    Collapse Awards and Honors
    Swiss National Science Foundation (SNSF)2018  - 2019Early Postdoc Mobility Fellowship, San Francisco
    College on Problems of Drug Dependence (CPDD)2018Travel Award for Early Career Investigators for the CPDD 80th Annual Scientific Meeting, San Diego
    National Institute on Drug Abuse (NIDA) 2018Travel Award for the SPR 26th Annual Meeting, Washington D.C.
    University of Zurich (UZH)2017Graduate Campus Grant for a 2-Day Workshop on Gender Equality & Early Career Development
    Training With Stakeholders – Applying EU Drug and Addiction Research (TWIST)2017Early Career Bursary for the 2nd Addictions, Lisbon
    International Society for the Study of Drug Policy (ISSDP) 2017  - `Travel Award for the 11th ISSDP conference, Aarhus
    German Society for Addiction Medicine (DGS) 20161st Place Short Talks, Berlin
    European Society of Prevention Research (EUSPR)2016Early Career Bursary for the 7th EUSPR Conference, Berlin
    Swiss Academy of Humanities and Social Sciences (SAGW)2015Travel Award for the 9th Club Health Conference, Lisbon
    Swiss Society of Addiction Medicine (SSAM)20151st Place Poster Award, Berne
    University of Zurich (UZH)2014Travel Award for a Research Stay at King’s College London
    Swiss Academy of Humanities and Social Sciences (SAGW)2013Travel Award for the 6th EUPHA Conference, Bruxelles

    Collapse Overview 
    Collapse Overview
    Dr. Larissa J. Maier is currently working as a postdoctoral research fellow at the Department of Psychiatry at UCSF. In the READI lab led by Dr. Danielle Ramo, Larissa aims to evaluate the impact of a smoking cessation intervention delivered via Facebook and to produce further valuable research on youth substance use that can help inform drug policy. Prior to this, she was appointed as a consultant in Drug Use Epidemiology at the United Nations Office on Drugs and Crime (UNODC). Furthermore, she has conducted significant addiction research studies at the Swiss Research Institute for Public Health and Addiction (ISGF), an affiliated institute of the University of Zurich. In March 2015, she completed her Ph.D. at the University of Zurich, where she specialized in Clinical and Health Psychology. Larissa is part of the Core Research Team of Global Drug Survey (GDS) aiming to make drug use safer, regardless of the legal status of the drug. Also, she is a member of the European Society of Prevention Research (EUSPR) and the related Early Career Forum, the International Society of Substance Use Professionals (ISSUP), the International Society for the Study of Drug Policy (ISSDP), the Society for Prevention Research (SPR), and the College on Problems of Drug Dependence (CPDD).


    Collapse Research 
    Collapse Research Activities and Funding
    Youth substance use - efficacy of social media interventions to reduce use and impact of state-level drug policies
    Swiss National Science Foundation (SNSF) P2ZHP1_174812Apr 1, 2018 - Sep 30, 2019
    Role Description: Early Postdoc Mobility Fellowship

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Maier L, Ferris JA, Winstock AR. Pharmacological cognitive enhancement among non-ADHD individuals-A cross-sectional study in 15 countries. Int J Drug Policy. 2018 Jun 11; 58:104-112. PMID: 29902691.
      View in: PubMed
    2. Changing the conversation to make drug use safer. Lancet. 2018 May 19; 391(10134):1965. PMID: 29864007.
      View in: PubMed
    3. Benfer I, Zahnow R, Barratt MJ, Maier L, Winstock A, Ferris J. The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries. Int J Drug Policy. 2018 May 03. PMID: 29731288.
      View in: PubMed
    4. Szigeti B, Winstock AR, Erritzoe D, Maier L. Are Ecstasy Induced Serotonergic Alterations Overestimated For The Majority Of Users? J Psychopharmacol. 2018 May 01; 269881118767646. PMID: 29733742.
      View in: PubMed
    5. Hughes CE, Barratt MJ, Ferris JA, Maier L, Winstock AR. Drug-related police encounters across the globe: How do they compare? Int J Drug Policy. 2018 Apr 23. PMID: 29699837.
      View in: PubMed
    6. Zahnow R, Winstock AR, Maier L, Levy J, Ferris J. Injecting drug use: Gendered risk. Int J Drug Policy. 2018 Mar 31; 56:81-91. PMID: 29614392.
      View in: PubMed
    7. Demant D, Oviedo-Trespalacios O, Carroll JA, Ferris JA, Maier L, Barratt MJ, Winstock AR. Do people with intersecting identities report more high-risk alcohol use and lifetime substance use? Int J Public Health. 2018 Mar 31. PMID: 29605878.
      View in: PubMed
    8. Barratt MJ, Ferris JA, Zahnow R, Palamar JJ, Maier L, Winstock AR. Moving on From Representativeness: Testing the Utility of the Global Drug Survey. Subst Abuse. 2017; 11:1178221817716391. PMID: 28924351.
      View in: PubMed
    9. Coney LD, Maier L, Ferris JA, Winstock AR, Barratt MJ. Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile. Hum Psychopharmacol. 2017 May; 32(3). PMID: 28517366.
      View in: PubMed
    10. Schaub MP, Blankers M, Lehr D, Boss L, Riper H, Dekker J, Goudriaan AE, Maier L, Haug S, Amann M, Dey M, Wenger A, Ebert DD. Efficacy of an internet-based self-help intervention to reduce co-occurring alcohol misuse and depression symptoms in adults: study protocol of a three-arm randomised controlled trial. BMJ Open. 2016 05 25; 6(5):e011457. PMID: 27225652; PMCID: PMC4885516.
    11. Maier L, Haug S, Schaub MP. Author's response on Arria (2016): Intention matters--using the terminology 'pharmacological neuroenhancement' as a behavioural definition based on the assumed functionality. Addiction. 2016 May; 111(5):938-9. PMID: 26956687.
      View in: PubMed
    12. Maier L, Liakoni E, Schildmann J, Schaub MP, Liechti ME. Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement. PLoS One. 2015; 10(12):e0144402. PMID: 26657300; PMCID: PMC4675521.
    13. Liakoni E, Schaub MP, Maier L, Glauser GV, Liechti ME. The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students. PLoS One. 2015; 10(10):e0141289. PMID: 26505633; PMCID: PMC4624689.
    14. Maier L, Haug S, Schaub MP. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. Drug Alcohol Depend. 2015 Nov 01; 156:221-227. PMID: 26455555.
      View in: PubMed
    15. Schaub MP, Maier L, Wenger A, Stark L, Berg O, Beck T, Quednow BB, Haug S. Erratum to: Evaluating the efficacy of a web-based self-help intervention with and without chat counseling in reducing the cocaine use of problematic cocaine users: the study protocol of a pragmatic three-arm randomized controlled trial. BMC Psychiatry. 2015 Sep 16; 15:218. PMID: 26376748; PMCID: PMC4574188.
    16. Maier L, Haug S, Schaub MP. Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel. Addiction. 2016 Feb; 111(2):280-95. PMID: 26189457.
      View in: PubMed
    17. Schaub MP, Maier L, Wenger A, Stark L, Berg O, Beck T, Quednow BB, Haug S. Evaluating the efficacy of a web-based self-help intervention with and without chat counseling in reducing the cocaine use of problematic cocaine users: the study protocol of a pragmatic three-arm randomized controlled trial. BMC Psychiatry. 2015 Jul 10; 15:156. PMID: 26159624; PMCID: PMC4496926.
    18. Maier L, Wunderli MD, Vonmoos M, Römmelt AT, Baumgartner MR, Seifritz E, Schaub MP, Quednow BB. Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality? PLoS One. 2015; 10(6):e0129805. PMID: 26107846; PMCID: PMC4479570.
    19. Maier L, Liechti ME, Herzig F, Schaub MP. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS One. 2013; 8(11):e77967. PMID: 24236008; PMCID: PMC3827185.
    Larissa's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Related Authors
    People who share related concepts with this person.
    _